Live Breaking News & Updates on Professor Zeng Xiaofeng

Stay updated with breaking news from Professor zeng xiaofeng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome

/PRNewswire/ RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced significant. ....

United States , Zhang Hong , Jianmin Fang , Zeng Xiaofeng , Remegen Co Ltd , Union Medical College Hospital , National Medical Products Administration , Prnewswire Remegen Co , Remegen Co , University First Hospital , Professor Zhang Hong , Peking University First , Professor Zeng Xiaofeng , Peking Union Medical College , Multidimensional Fatigue Inventory ,

RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal

/PRNewswire/ RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, has. ....

United Kingdom , United States , Zeng Xiaofeng , Jianmin Fang , Union Medical College Hospital , Department Of Rheumatology , Oxford University , Remegen Co , British Society For Rheumatology , Oxford University Press , Prnewswire Remegen Co Ltd , British Society , Professor Zeng Xiaofeng , Peking Union Medical College Hospital , Chief Scientific Officer , Remegen Co ,